Congo, Democratic Republic of the vs Timor-Leste: Treatment success rate for patients treated for MDR-TB
Congo, Democratic Republic of the
96.0%
in 2022
Timor-Leste
95.0%
in 2022
Congo, Democratic Republic of the rank
17th
Timor-Leste rank
18th
Treatment success rate for patients treated for MDR-TB over time
- Congo, Democratic Republic of the
- Timor-Leste
How they compare
Congo, Democratic Republic of the currently reports 96.0% against 95.0% in Timor-Leste, a difference of 1.0%.
The two have swapped places 6 times across 14 shared years of data; in 2009 it was Congo, Democratic Republic of the ahead.
Congo, Democratic Republic of the ranks 17th and Timor-Leste ranks 18th of 163 countries.
Across the 3 decades both report, Congo, Democratic Republic of the averaged higher in 2 and Timor-Leste in 1.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.0% | 0.0% | 33.0% | Congo, Democratic Republic of the |
| 2010s | 71.6% | 75.0% | 3.4% | Timor-Leste |
| 2020s | 94.3% | 86.7% | 7.7% | Congo, Democratic Republic of the |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Congo, Democratic Republic of the or Timor-Leste?
- Congo, Democratic Republic of the, at 96.0% against 95.0% in Timor-Leste as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Congo, Democratic Republic of the and Timor-Leste?
- 1.0%, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Timor-Leste?
- 14 years are reported by both, from 2009 to 2022.
- How do Congo, Democratic Republic of the and Timor-Leste rank globally for treatment success rate for patients treated for mdr-tb?
- Congo, Democratic Republic of the ranks 17th and Timor-Leste ranks 18th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.